“…Of the other effects of the drugs the changes which some induce in brain sodium, potassium-activated, magnesium-dependent adenosine triphosphatase (Na+,K+-ATPase, EC.3.6.1.3) activity, thereby influencing ion gradients, are of particular interest. However, whilst there is little doubt that phenytoin (diphenylhydantoin) can influence brain .Na+,K+-ATPase activity, whether inhibition or stimulation results appears to depend upon the concentrations of sodium and potassium ions in the assay medium (Festoff & Appel, 1968;Rawson & Pincus, 1968;Formby, 1970;Woodbury & Kemp, 1970;Gilbert, Buchan & Scott, 1974a;Gilbert & Wylie, 1974b;Koostra & Woodhouse, 1974). The anticonvulsant ethosuximide also inhibits Na+,K+-ATPase but previous experiments in this laboratory have failed to detect effects of phenobarbitone or acetazolamide on the activity of the enzyme ).…”